Stifel Financial Corp Has $1.65 Million Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Stifel Financial Corp decreased its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 1.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 64,385 shares of the company’s stock after selling 1,087 shares during the period. Stifel Financial Corp owned 0.11% of ARK Genomic Revolution ETF worth $1,648,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Elmwood Wealth Management Inc. lifted its holdings in shares of ARK Genomic Revolution ETF by 39.7% during the third quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock worth $1,479,000 after buying an additional 16,412 shares in the last quarter. Atom Investors LP raised its stake in ARK Genomic Revolution ETF by 15.2% in the 3rd quarter. Atom Investors LP now owns 49,131 shares of the company’s stock worth $1,258,000 after purchasing an additional 6,496 shares in the last quarter. Rothschild Investment LLC acquired a new stake in ARK Genomic Revolution ETF in the 2nd quarter worth about $262,000. Mercer Global Advisors Inc. ADV boosted its holdings in ARK Genomic Revolution ETF by 901.5% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 28,943 shares of the company’s stock valued at $680,000 after purchasing an additional 26,053 shares during the period. Finally, Brown Miller Wealth Management LLC grew its position in shares of ARK Genomic Revolution ETF by 5.5% during the 3rd quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after purchasing an additional 933 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

BATS ARKG opened at $23.68 on Friday. The company has a fifty day simple moving average of $24.75 and a 200 day simple moving average of $25.08.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.